Fri, Aug 29, 2014, 12:24 PM EDT - U.S. Markets close in 3 hrs 36 mins

Recent

% | $
Quotes you view appear here for quick access.

Stereotaxis Inc. Message Board

trainingforoldage 13 posts  |  Last Activity: Aug 14, 2014 4:15 PM Member since: May 11, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • trainingforoldage by trainingforoldage Aug 14, 2014 4:15 PM Flag

    A hint: If you click on the posters name, you can pull up their entire history of posting. Then, if you find and report their abusive, obscene, and derogatory posts from the past, Yahoo! will be far more likely to ban them from posting in the future. It doesn't take long, and forcing the trolls to create a new ID is always a good deed!

  • trainingforoldage by trainingforoldage Aug 11, 2014 2:38 PM Flag

    ...meh, could have been better.....but the capital equipment backlog is strong, utilization trend continues its upward momentum, cost containment measures continue to be very effective, and margins are still VERY strong. All of these HARD FACTS point to the growing clinical acceptance of STXS technology and products. With new products awaiting regulatory approval and new market opportunities expanding in Asia, I continue to be.....

    Strong Long, STRONG Buy

    Hold onto your shares, fellow longs!

    TFOA

    Sentiment: Strong Buy

  • trainingforoldage by trainingforoldage Jul 29, 2014 2:23 PM Flag

    I made MY prediction a while ago.....LESS than 3M. I'll add that they will have given away more robots in Q2 than they sold. Also, during Q2 utilization will have continued its long slide to oblivion. Face it, this company is based on an inappropriate use of otherwise interesting technology. The two most important things a medical device company has to be able to demonstrate with its products, safety and efficacy, have never been an element of the business model for HNSN.

    TFOA

  • Reply to

    Anyone else annoyed by UA Spam?

    by trainingforoldage Jul 24, 2014 7:19 PM
    trainingforoldage trainingforoldage Jul 28, 2014 2:34 PM Flag

    Well, in regards to the question of ISRG being a suitor for STXS....... Yeah, good question. Hansen IS on mighty thin ice. I have no idea what happens to their IP license / non-compete agreement with ISRG if hansen were to cease operations; would an entity who bought the product lines from hnsn be protected from competition from ISRG? That sounds unlikely, doesn't it? This could crack the door open....

    Maybe there will be an opportunity for ISRG to be a suitor for STXS .....BUT, .I'm not in favor of anyone buying STXS now....I am confident we are at the beginning of a period of revenue growth that will be very hockey-stick like in appearance. Far better for the trailing revs to be over 100M when considering STXS being an acquisition target.

    Hold onto your shares, fellow longs!

    TFOA STILL Strong Long, STILL Strong Buy

    Sentiment: Strong Buy

  • trainingforoldage by trainingforoldage Jul 24, 2014 7:19 PM Flag

    Please report spam.

  • Reply to

    Buyout?

    by acek70 Jul 22, 2014 9:45 AM
    trainingforoldage trainingforoldage Jul 24, 2014 2:53 PM Flag

    Day-dreaming about ISRG buying STXS is a waste of time. When ISRG helped start HNSN by licensing some of their technology to HNSN for use only in procedures requiring vascular access, ISRG agreed to not compete with HNSN in robotic procedures requiring vascular access. It's pretty obvious that ISRG acquiring STXS would be a violation of that agreement. There may be suitors for STXS someday....but ISRG isn't likely to be among the crowd.

    Sentiment: Strong Buy

  • Reply to

    APRU-All you can eat in this buffet…

    by dresydmatop1980 Jul 17, 2014 1:52 PM
    trainingforoldage trainingforoldage Jul 17, 2014 8:00 PM Flag

    Sub Penny-stock scammers are busy...what you need to know about APRU: 4.5 BILLION shares outstanding........Revs in the LOW thousands....I guess we can understand why the sub-penny stock scammers spam these boards, it costs nothing...but, c'mon, Man.....

    Sentiment: Strong Sell

  • trainingforoldage by trainingforoldage Jul 11, 2014 2:25 PM Flag

    It's understandable that the Penny Stock Spammers spend a lot of energy barking on these boards, because it is free, and day-traders might be silly enough to make trading decisions based on what they find here; but REALLY, a sub-penny stock with over 4 billion shares outstanding, and the business model is........medical devices for dogs?!!!

    Sentiment: Strong Sell

  • trainingforoldage by trainingforoldage Jul 10, 2014 4:53 PM Flag

    Low analyst estimate for Q2 is 4.2m.....I'm guessing it will actually be less than 3.0m.....

    TFOA

    Sentiment: Strong Sell

  • trainingforoldage by trainingforoldage Jun 27, 2014 4:57 PM Flag

    Oooph! A couple more days like today and it might be tough to raise enough capital later this ;year to satisfy the debt covenants regarding minimum cash reserves....every day like this makes the upcoming dilution uglier. Any longs out there who can shed some light on what is floating their boats these days?

    TFOA

    Sentiment: Strong Sell

  • trainingforoldage by trainingforoldage Jun 10, 2014 9:26 PM Flag

    So did Peter wake up and smell the coffee, or was he shown the door? My guess is he didn't want to be at the switch either when the next big dilution hits, or, if / when the stock drops under a buck, and the NASDAQ delisting happens!

    Whatever, the revolving door to the executive suite is still spinning!

    TFOA

  • trainingforoldage by trainingforoldage Jun 10, 2014 2:25 PM Flag

    Hold onto your shares, fellow longs! There should be a series of very significant press releases coming up!

    Still Strong Long, Still Strong Buy!

    TFOA

    Sentiment: Strong Buy

  • Reply to

    Clairvoyance

    by buckeyetp May 31, 2014 7:31 PM
    trainingforoldage trainingforoldage Jun 2, 2014 3:25 PM Flag

    The surgical robotics space may be wide open, but NOT for hnsn. Their original, company founding, IP licensing agreement with ISRG allows them to only use the IP for procedures requiring vascular acccess. They are barred from using the IP for any other type of surgical procedure.

    Further, each new vascular procedure they want to be indicated for requires a new 510(k), which for hnsn is NOT a slam-dunk. for example, they just terminated a five year-old clinical trial on April 1 that was meant to demonstrate safety and efficacy for using Sensei for EP ablation procedures, because (as hnsn stated to FDA) "preliminary results indicated they were unlikely to meet safety and efficacy endpoints"

    Hansen does not have "spectacular technology". Their "stiff catheter push-deflect" technology is interesting and may have many robotic medical procedure applications, but IMHO it is inappropriate for use in procedures requiring vascular access. Note that they have licensed back to ISRG all of their improvements to the "stiff catheter push-deflect technology, which ISRG will find good use for in other surgical robotics applications.

    The sale of ALL of their current and future IP to ISRG also puts a FIRM clamp on any day-dreaming about them being acquired by ISRG........ISRG already owns everything of value to them at Hansen. There is nothing for them to buy!

    Hnsn has been a dead-man walking for a long time. They have one more clinical trial underway to try to establish safety and efficacy for using Sensei in EP ablation procedures. If you believe they have any chance at all of succeeding in that trial, you still have to overlook their revenue history (especially their close-to negative margins, as they have been basically giving away their product to try to kick start clinical acceptance). Their financial history also leads you to look at their solvency. There is a massive dilution coming up later this year!

    Buyer beware!

    TFOA

    Sentiment: Strong Sell

STXS
2.95+0.05(+1.72%)12:21 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.